NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,888 | -0.6% | 126,524 | -1.6% | 0.89% | +4.2% |
| Q2 2023 | $12,971 | +6.0% | 128,536 | -3.4% | 0.85% | +1.0% |
| Q1 2023 | $12,241 | -4.1% | 133,051 | -5.5% | 0.84% | -10.2% |
| Q4 2022 | $12,769 | -99.9% | 140,755 | +0.8% | 0.94% | +13.8% |
| Q3 2022 | $10,612,000 | -8.5% | 139,608 | +1.7% | 0.82% | -5.3% |
| Q2 2022 | $11,599,000 | +3.1% | 137,221 | +7.0% | 0.87% | +26.5% |
| Q1 2022 | $11,252,000 | -0.7% | 128,224 | -1.1% | 0.69% | +7.0% |
| Q4 2021 | $11,337,000 | +7.2% | 129,615 | +0.2% | 0.64% | -0.8% |
| Q3 2021 | $10,578,000 | -10.8% | 129,351 | -0.5% | 0.65% | -10.9% |
| Q2 2021 | $11,860,000 | -14.5% | 129,981 | -19.9% | 0.73% | -21.4% |
| Q1 2021 | $13,877,000 | -24.6% | 162,347 | -16.7% | 0.92% | -26.5% |
| Q4 2020 | $18,408,000 | +5.7% | 194,942 | -2.6% | 1.26% | -6.3% |
| Q3 2020 | $17,408,000 | -3.7% | 200,182 | -3.2% | 1.34% | -15.1% |
| Q2 2020 | $18,069,000 | -9.7% | 206,887 | -14.7% | 1.58% | -30.6% |
| Q1 2020 | $20,002,000 | -16.6% | 242,591 | -4.2% | 2.28% | -1.4% |
| Q4 2019 | $23,980,000 | +6.1% | 253,252 | -2.6% | 2.31% | -4.2% |
| Q3 2019 | $22,602,000 | -11.0% | 260,092 | -6.5% | 2.41% | -11.4% |
| Q2 2019 | $25,406,000 | -11.3% | 278,238 | -6.6% | 2.72% | -14.0% |
| Q1 2019 | $28,634,000 | +12.4% | 297,841 | +0.3% | 3.17% | -6.3% |
| Q4 2018 | $25,479,000 | -0.5% | 296,918 | -0.1% | 3.38% | +12.3% |
| Q3 2018 | $25,619,000 | +14.6% | 297,345 | +0.4% | 3.01% | +5.5% |
| Q2 2018 | $22,362,000 | -16.6% | 296,030 | -10.7% | 2.85% | -15.9% |
| Q1 2018 | $26,806,000 | +8.6% | 331,552 | +12.8% | 3.39% | +4.8% |
| Q4 2017 | $24,677,000 | -6.2% | 293,915 | -4.1% | 3.23% | -5.7% |
| Q3 2017 | $26,312,000 | +6.3% | 306,484 | +3.3% | 3.43% | +3.5% |
| Q2 2017 | $24,757,000 | +12.3% | 296,595 | -0.1% | 3.31% | +9.5% |
| Q1 2017 | $22,040,000 | -3.8% | 296,756 | -5.6% | 3.03% | -6.9% |
| Q4 2016 | $22,906,000 | -6.3% | 314,474 | +1.5% | 3.25% | -8.7% |
| Q3 2016 | $24,458,000 | -4.0% | 309,751 | +0.3% | 3.56% | -3.7% |
| Q2 2016 | $25,487,000 | +26.8% | 308,894 | +11.3% | 3.70% | +24.3% |
| Q1 2016 | $20,105,000 | -8.9% | 277,537 | +8.2% | 2.98% | -17.7% |
| Q4 2015 | $22,063,000 | -1.6% | 256,423 | +5.1% | 3.62% | -7.4% |
| Q3 2015 | $22,429,000 | -3.3% | 244,002 | +3.4% | 3.91% | +3.1% |
| Q2 2015 | $23,206,000 | +3.5% | 235,973 | +3.8% | 3.79% | -1.6% |
| Q1 2015 | $22,415,000 | +9.8% | 227,308 | +3.2% | 3.85% | +7.5% |
| Q4 2014 | $20,419,000 | -2.4% | 220,366 | -0.9% | 3.58% | -9.9% |
| Q3 2014 | $20,922,000 | +36.6% | 222,280 | +31.4% | 3.98% | +14.1% |
| Q2 2014 | $15,315,000 | +7.4% | 169,166 | +0.8% | 3.49% | +3.2% |
| Q1 2014 | $14,264,000 | +8.4% | 167,777 | +2.5% | 3.38% | +3.8% |
| Q4 2013 | $13,153,000 | +6.0% | 163,637 | +1.2% | 3.25% | -5.5% |
| Q3 2013 | $12,405,000 | +9.7% | 161,717 | +1.1% | 3.44% | +2.6% |
| Q2 2013 | $11,313,000 | – | 159,997 | – | 3.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |